India's drug regulator plans new rules for medicine marketers. Companies will need a license to sell and distribute drugs. This aims to imp...

The Delhi High Court has ordered the Indian government to take action against the illegal online sale of drugs. The court has given the gov...

In the notices, issued on Wednesday, the regulator said the online platforms were doing the business in contravention of the Drugs and Cosm...

This comes after the Madras High Court, in a recent injunction, restrained unlicenced e-pharmacies from doing business.

Only one Indian drug maker, Emcure, will be allowed to sell the medicine in the Indian private market, because of a licensing agreement wit...

The licences and approvals can be made perpetual provided they are not cancelled or suspended by the licencing authority, according to the ...

He said a number of representations have been received from chemists and druggist associations against online sale of prescription drugs.

The Delhi High Court has upheld the patent of US-based BMS for Dasatinib, dashing the hopes of a local company to sell a generic version of...

The Indian Patent Office had in 2013 rejected the company’s demand for a compulsory licence as it did not follow the procedures for obtaini...

"We will not give you an interim order. We will hear it on an early date and dispose it of. Notice. Renotify on February 5," the bench said.

Under the Indian Patents Act, if a medicine is deemed unaffordable, a compulsory licence can be issued to a generic drug maker in public in...

IPAB has postponed German company Bayer AG's appeal against the grant of a compulsory licence of its patented drug Nexavar to Natco Pharma ...

Hyderabad-based generic drugmaker Natco Pharma has started selling copies of global pharma major Bristol Myers Squibb's cancer drug Dasatin...

The government has clarified that no applications are pending from pharmaceutical companies seeking compulsory licences for producing low-c...

The government has allowed a local drugmaker Natco Pharma to make and sell a patented cancer drug at a fraction of the price charged by Ger...

Natco Pharma plans to seek a compulsory licence to make Bayer AG's Nexavar in India, invoking a provision in local laws that allows generic...

The government is set to put Zanamivir, the only swine flu drug that is freely available in the market, currently, under restricted sale ca...